Drugs / PN-196,444
last change Mar 2003 re-read 3 minutes ago

PN-196,444

Developed for
thrombocytopenia
Investigated by
Pfizer

Trials 1

2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00039910 Jul 2000 → Mar 2003 Hodgkins lymphoma, non-Hodgkin lymphoma, thrombocytopenia Pfizer Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PN-196,444 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00039910 ↗